Skip to main content
First Denosumab Biosimilar Approved in Two Different Formulations
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
First Denosumab Biosimilar Approved in Two Different Formulations
User login
Username
Password
Reset your password
Concept
Lead
score
Osteoporosis
1
1
Biologic Therapy
0
1
Biosimilars
0
0.71
Bone
0
0.44
Fractures
0
0.43
Breast Cancer
0
0.32
Bone Metastasis
0
0.31
Metastasis
0
0.28
Cancer
0
0.27
Grant
0
0.27
Prostate Cancer
0
0.26
Giant Cell Tumor
0
0.19
Tumor
0
0.18
Multiple Myeloma
0
0.15
Adolescent Medicine
0
0.09
Aromatase Inhibitors
0
0.09
Bisphosphonate
0
0.09
Breast
0
0.09
Canada
0
0.09
Clinical Research
0
0.09
Contraception
0
0.09
Food and Drug Administration (FDA)
0
0.09
Glucocorticoid
0
0.09
Healthcare and Medical Technology
0
0.09
Hypercalcemia
0
0.09
Hypocalcemia
0
0.09
Pregnancy
0
0.09
Prostate
0
0.09
Refractory
0
0.09
Resection
0
0.09
Skeletal
0
0.09
Specialty
Lead
score
Diabetes & Endocrinology
1
1
Family Medicine/Primary Care
0
1
Pharmacist
0
1
Orthopaedics
0
0.83
Hematology-Oncology
0
0.73
Urology
0
0.68
Internal Medicine
0
0.64
Pediatrics
0
0.54
Rheumatology
0
0.51
Emergency Medicine
0
0.49
Ob/Gyn & Women's Health
0
0.42
Nephrology
0
0.36
Edit Tags